| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $337.2M | +9.3% | +25.7% |
| Cost of Revenue | $133.2M | +13.9% | +26.1% |
| R&D Expense | $29.8M | -2.5% | +30.7% |
| SG&A Expense | $56.4M | -9.3% | +11.7% |
| Operating Income | $8.8M | +271.4% | +170.7% |
| Interest Expense | -$180K | -208.4% | -109.3% |
| Pre-tax Income | -$2.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $385.2M | +5.4% | -8.0% |
| Accounts Receivable | $272.3M | +8.5% | +33.7% |
| Current Assets | $689.1M | +9.3% | +8.7% |
| Total Assets | $1.15B | +4.6% | +32.4% |
| Current Liabilities | $228.8M | +18.0% | +19.8% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $134.8M | — | — |
| Capital Expenditures | $10.6M | — | — |
| Investing Cash Flow | -$26.9M | — | — |
| Financing Cash Flow | -$88.7M | — | — |
| Free Cash Flow | $124.2M | — | — |
| +76.0% |
| +83.7% |
| Income Tax | $840K | -29.5% | +320.0% |
| Net Income | -$3.6M | +71.6% | +79.1% |
| EPS (Basic) | -$0.02 | +66.7% | +77.8% |
| EPS (Diluted) | -$0.02 | +66.7% | +77.8% |
| $196.9M |
| +0.1% |
| +0.4% |
| Total Liabilities | $461.6M | +8.1% | +17.1% |
| Stockholders' Equity | $689.2M | +2.4% | +45.1% |